BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15158606)

  • 41. An Unmutated IgM Response to the Vi Polysaccharide of
    Pandya KD; Palomo-Caturla I; Walker JA; K Sandilya V; Zhong Z; Alugupalli KR
    J Immunol; 2018 Jun; 200(12):4078-4084. PubMed ID: 29743315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of an outer membrane protein of Salmonella enterica serovar typhimurium that confers protection against typhoid.
    Hamid N; Jain SK
    Clin Vaccine Immunol; 2008 Sep; 15(9):1461-71. PubMed ID: 18650399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study on the production of IgG, IgA- and IgM-antibodies to somatic antigens of Salmonella typhi in humans.
    Chernokhvostova E; Luxemburg KI; Starshinova V; Andreeva N; German G
    Clin Exp Immunol; 1969 Apr; 4(4):407-21. PubMed ID: 4182404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active protection of mice against Salmonella typhi by immunization with strain-specific porins.
    Isibasi A; Ortiz-Navarrete V; Paniagua J; Pelayo R; González CR; García JA; Kumate J
    Vaccine; 1992; 10(12):811-3. PubMed ID: 1333686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon-γ and proliferation responses to Salmonella enterica Serotype Typhi proteins in patients with S. Typhi Bacteremia in Dhaka, Bangladesh.
    Sheikh A; Khanam F; Sayeed MA; Rahman T; Pacek M; Hu Y; Rollins A; Bhuiyan MS; Rollins S; Kalsy A; Arifuzzaman M; Leung DT; Sarracino DA; Krastins B; Charles RC; Larocque RC; Cravioto A; Calderwood SB; Brooks WA; Harris JB; Labaer J; Qadri F; Ryan ET
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1193. PubMed ID: 21666798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi.
    Singh M; Ganguly NK; Kumar L; Vohra H
    Microbiol Immunol; 1999; 43(6):535-42. PubMed ID: 10480549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maternal antibodies arm neonatal leukocytes against "Salmonella typhi" at birth.
    Romano M; De Magistris MT; Villa L; Nencioni L; De Leo V; Tagliabue A
    Ann Sclavo Collana Monogr; 1986; 3(1-2):93-8. PubMed ID: 3426883
    [No Abstract]   [Full Text] [Related]  

  • 49. Detection of antibodies against Salmonella typhi outer membrane protein (OMP) preparation in typhoid fever patients.
    Verdugo-Rodriguez A; Gam LH; Devi S; Koh CL; Puthucheary SD; Calva E; Pang T
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):45-52. PubMed ID: 8216558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies of cellular and humoral immunity in typhoid fever and TAB vaccinated subjects.
    Dham SK; Thompson RA
    Clin Exp Immunol; 1982 May; 48(2):389-95. PubMed ID: 7105490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification of integral outer-membrane protein OmpC, a surface antigen from Salmonella typhi for structure-function studies: a method applicable to enterobacterial major outer-membrane protein.
    Arockiasamy A; Krishnaswamy S
    Anal Biochem; 2000 Jul; 283(1):64-70. PubMed ID: 10929809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of immune response during typhoid fever in man.
    Sarma VN; Malaviya AN; Kumar R; Ghai OP; Bakhtary MM
    Clin Exp Immunol; 1977 Apr; 28(1):35-9. PubMed ID: 862249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance characteristics of an enzyme-linked immunosorbent assay for the determination of immunoglobulin M anti-Salmonella typhi lipopolysaccharide antibodies.
    Nardiello S; Pizzella T; Migliaresi S; Galanti B
    Boll Ist Sieroter Milan; 1985; 64(2):155-9. PubMed ID: 3896258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of systemic and mucosal immune response in mice immunised with porins of Salmonella typhi.
    Singh M; Vohra H; Kumar L; Ganguly NK
    J Med Microbiol; 1999 Jan; 48(1):79-88. PubMed ID: 9920129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.
    Sánchez-Ramón S; de Gracia J; García-Alonso AM; Rodríguez Molina JJ; Melero J; de Andrés A; García Ruiz de Morales JM; Ferreira A; Ocejo-Vinyals JG; Cid JJ; García Martínez JM; Lasheras T; Vargas ML; Gil-Herrera J; García Rodríguez MC; Castañer JL; González Granado LI; Allende LM; Soler-Palacin P; Herráiz L; López Hoyos M; Bellón JM; Silva G; Gurbindo DM; Carbone J; Rodríguez-Sáinz C; Matamoros N; Parker AR; Fernández-Cruz E;
    Clin Immunol; 2016 Aug; 169():80-84. PubMed ID: 27236002
    [No Abstract]   [Full Text] [Related]  

  • 57. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
    Zhou WZ; Koo HW; Wang XY; Zhang J; Park JK; Zhu F; Deen J; Acosta CJ; Chen Y; Wang H; Galindo CM; Ochiai L; Park T; von Seidlein L; Xu ZY; Clemens JD
    Pediatr Infect Dis J; 2007 Nov; 26(11):1001-5. PubMed ID: 17984806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression, purification, and immunogenicity of recombinant porin proteins of Salmonella enterica serovar Typhi (S. Typhi).
    Kumar VS; Gautam V; Balakrishna K; Kumar S
    J Microbiol Biotechnol; 2009 Sep; 19(9):1034-40. PubMed ID: 19809263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
    Kawahara M
    Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and purification of antigenic 34 kDa outer membrane protein of Salmonella typhi.
    Aslam MS; Akhter M; Rasheed R; Samra ZQ; Gull I; Athar MA
    Clin Lab; 2012; 58(9-10):1071-7. PubMed ID: 23163127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.